Craft

PharmaCyte Biotech

Stock Price

$1.9

2024-10-29

Market Capitalization

$14.7 M

2024-10-29

PharmaCyte Biotech Summary

Company Summary

Overview
PharmaCyte Biotech is a clinical-stage biotechnology company focused on developing and preparing to commercialize treatments for cancer and diabetes. It uses its proprietary cellulose-based live-cell encapsulation technology known as Cell-in-a-Box. The company also offers cannabis-based drugs for medical use to treat conditions such as nausea, vomiting, and pain.
Type
Public
Status
Active
Founded
1996
HQ
Laguna Hills, CA, US | view all locations
Website
https://pharmacyte.com/
Cybersecurity rating
Sectors

Key People

  • José Iglesias

    José Iglesias, Consulting Chief Medical Officer

    • Carlos A. Trujillo

      Carlos A. Trujillo, Chief Financial Officer and Director

      LocationsView all

      1 location detected

      • Laguna Hills, CA HQ

        United States

        23046 Avenida De La Carlota #600

      PharmaCyte Biotech Financials

      Summary Financials

      Net income (Q3, 2026)
      $746.9K
      Cash (Q3, 2026)
      $20.2M
      EBIT (Q3, 2026)
      ($2.1M)

      Footer menu